Tag: CORO
Nirmatrelvir Plus Ritonavir Reduces Risks for COVID-19 in Seniors
Reduced risks for hospitalization and death observed for mainly vaccinated outpatients aged 50 years or older with COVID-19
Viral Rebound Uncommon After Molnupiravir, Nirmatrelvir-Ritonavir Therapy
Viral rebound uncommon with treatment for patients hospitalized with COVID-19 and not associated with increased mortality
Paxlovid Safe for Pregnant Patients With COVID-19
However, unexpectedly high rate of cesarean deliveries seen in this cohort
FDA Approves Bivalent COVID-19 Boosters for Children 6 Months and Older
Updated boosters protect against both the original strain of COVID-19 and highly contagious omicron variants
COVID-19 Vaccine Prevents Against Reinfection
Findings show protection for all variant periods
Paxlovid Soon Will Not Be Free for Americans
At this point, about 6 million Americans have taken free Paxlovid doses
SGLT-2i Use Before COVID-19 May Reduce Adverse Outcomes in Diabetes Patients
SGLT-2is associated with lowest probability for adverse outcomes followed by glucagon-like peptide-1 receptor agonists, metformin
41.6 Percent of Adults Have Serology Indicative of Past COVID-19 Infection
25.5 percent of those whose serology indicated past infection reported not having been vaccinated, with higher rates seen in young, Black adults
Feds Urge Vaccination as ‘Tripledemic’ Hits More Americans
Vaccination will be key to keeping patients healthy through the winter holidays
Pfizer Asks FDA to Approve Tweaked COVID-19 Booster as Third Shot for Under 5s
Though children aged 5 years and older and adults need only two doses to complete a primary series, younger children need three doses